Phathom Pharmaceuticals (PHAT) stock rises as Cantor Fitzgerald issues an Overweight rating, rejecting its IP-rights related ...
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target Maximize Your Portfolio ...
Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...
After hours: February 12 at 4:00:20 PM EST Loading Chart for PROF ...
After hours: February 7 at 7:52:37 PM EST Loading Chart for RLMD ...
After hours: 7:58:50 p.m. EST ...
After hours: February 13 at 4:01:56 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback